Catalyst Wire Dossier Catalyst Wire Dossier

Anagrelide Retard

anagrelide · AOP Orphan Pharmaceuticals AG
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Anagrelide Retard, covering 2015-07-29 to 2016-05-26. Get the full timeline:

Most recent: Clinical Trial Update: Anagrelide Retard vs. Placebo: Efficacy and Safety in "At-risk" Patients With Essential Thrombocythaemia [Phase 3]

See pricing